Dr. Guy Hatchard highlights a report this week that indicates the biotechnology industry is experiencing a collapse. Many companies are undergoing restructuring, layoffs and pipeline cuts due to a lack of viable products. This is good news as the biotechnology industry has failed the public. The consequences of those failures are far-reaching including a rise| The Expose - Home